5 Results for "

AD brain homogenates

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "AD brain homogenates" in MCE Product Catalog:

Cat. No.: HY-101182
CAS No.: 1374107-54-6
Purity:  98.52%
Target:  

Microtubule/Tubulin

Research Areas:  

Neurological Disease

THK-5117, an arylquinoline derivative, displays high binding affinity to tau fibrils with a Ki of 10.5 nM. THK-5117 has high binding affinity to tau protein aggregates and tau-rich Alzheimer disease (ADbrain homogenates. 18F-THK-5117 has the potential to act as a tau imaging PET probe .
loading...
    loading...
Cat. No.: HY-101181
CAS No.: 1374107-46-6
Target:  

Microtubule/Tubulin

Research Areas:  

Neurological Disease

THK-5105, an arylquinoline derivative, displays high binding affinity to tau fibrils. THK-5105 has high binding affinity to tau protein aggregates and tau-rich Alzheimer disease (ADbrain homogenates. 18F-THK-5105 has the potential to act as a tau imaging PET probe .
loading...
    loading...
Cat. No.: HY-167898
CAS No.: 955376-42-8
Target:  

Amyloid-β

Research Areas:  

Neurological Disease

MeS-IMPY is a ligand of β-amyloid plaques. MeS-IMPY shows a high binding affinity to β-amyloid plaques extracted from Alzheimer's disease (AD) human brains or AD brain homogenates compared to IMPY (Ki=7.93 and 8.95 nM, respectively). [ 11C]MeS-IMPY is a potential radioligand for imaging β-amyloid plaques with positron emission tomography (PET) .
loading...
    loading...
Cat. No.: HY-185545
CAS No.: 2922277-92-5
NTRK1-ligand-1 (Compound 15) is a NTRK1 ligand. NTRK1-ligand-1 serves as a Ligand for Target Protein for PROTAC, which is applicable to the development and design of PROTAC NTRK1 degraders, such as PROTAC NTRK1 degrader-1 (HY-181052). NTRK1-ligand-1 can be used in the research of solid tumors .
loading...
    loading...
Cat. No.: HY-P99648A
CAS No.: 1788032-39-2
Synonyms: BMS-986168 (powder); IPN007 (powder); BIIB092 (powder)

Target:  

Tau Protein

Research Areas:  

Neurological Disease

Gosuranemab (BMS-986168; IPN007; BIIB092) (powder) is a humanised IgG4 anti-tau monoclonal antibody. Gosuranemab (powder) neutralizes the extracellular tau protein, inhibiting the spread and aggregation of pathological tau protein. Gosuranemab (powder) can be used for the research of progressive supranuclear palsy and early Alzheimer’s disease .
loading...
    loading...